
CVS Health Corporation (CVS) recently raised its adjusted EPS guidance range to $8.55 to $8.65 from $8.40 to $8.60. Moreover, it surpassed revenue estimates by 5.7% and EPS estimates by 7.9% for the 2022 third quarter.
“We continue to execute on our strategy with a focus on expanding capabilities in health care delivery, and the announced acquisition of Signify Health will further strengthen our engagement with consumers,” Karen S. Lynch, CVS’ CEO, said.